Evidence map›Paper›PMID 38494873›Full record

ReviewJournal of psychopharmacology (Oxford, England)2024

Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II.

Samuele Cortese, Frank Mc Besag, Bruce Clark, Chris Hollis, Joe Kilgariff, Carmen Moreno, Dasha Nicholls, Paul Wilkinson, Marc Woodbury-Smith, Aditya Sharma

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of psychopharmacology (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 4 countries.

Samuele CorteseCentre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.ORCID 0000-0001-5877-8075
Frank Mc BesagUCL School of Pharmacy, London, UK.
Bruce ClarkNational Specialist Clinic for Young People with OCD, BDD and Related Disorders, South London and Maudsley NHS Foundation Trust, London, UK.
Chris HollisDepartment of Child and Adolescent Psychiatry, Nottinghamshire Healthcare NHS Foundation Trust, Queen's Medical Centre, Nottingham, UK.
Joe KilgariffDepartment of Child and Adolescent Psychiatry, Nottinghamshire Healthcare NHS Foundation Trust, Queen's Medical Centre, Nottingham, UK.ORCID 0000-0002-7195-7753
Carmen MorenoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain.ORCID 0000-0003-0541-4846
Dasha NichollsDivision of Psychiatry, Imperial College London, London, UK.
Paul WilkinsonSchool of Clinical Medicine, University of Cambridge, Cambridge, Cambridgeshire, UK.
Marc Woodbury-SmithBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Aditya SharmaAcademic Psychiatry, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Nottinghamshire Healthcare NHS Foundation Trust · GBCumbria Northumberland Tyne and Wear NHS Foundation Trust · GBEast London NHS Foundation Trust · GBInstituto de Salud Carlos III · ESNewcastle University · GBNorth West London Pathology · GBSolent NHS Trust · GBSouth London and Maudsley NHS Foundation Trust · GBUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As Faculty of the British Association for Psychopharmacology course on child and adolescent psychopharmacology, we present here what we deem are the most common pitfalls, and how to avoid them, in child and adolescent psychopharmacology. In this paper, we specifically addressed common pitfalls in the pharmacological treatment of autism and intellectual disability, eating disorders, neuropsychiatric correlates of epilepsy, and psychosis. Pitfalls in relation to the treatment of other disorders are addressed in a separate paper (Part I).

Indexed as

Autistic DisorderFeeding and Eating DisordersIntellectual DisabilityPsychopharmacologyPsychotic DisordersAdolescentChildHumansadolescentschildrenexpert opinionpitfallsPsychopharmacologyyoung people

Identifiers

PMID38494873
PMCPMC11010553
OpenAlexW4392925817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.